Study to Evaluate the Clinical Efficacy and Safety of Tamsulosin Alone or in Combination With Solifenacin for the Treatment in Men With Lower Urinary Tract Symptoms Including Overactive Bladder Symptoms

Phase 4 Completed 52 enrolled Astellas Pharma Taiwan, Inc.

RandomizedParallel-groupOpen-labelTreatment

Summary

The objective of this study is to evaluate the clinical efficacy and safety of tamsulosin alone or in combination with solifenacin for the treatment in men with lower urinary tract symptoms (LUTS) including overactive bladder (OAB) symptoms in Taiwan.

Timeline

Start: 2007-09
Primary completion: 2011-04
Completion: 2011-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Solifenacin	Small molecule	—	Oral
Subject	Tamsulosin	Other / unclassified	—	Oral

Study to Evaluate the Clinical Efficacy and Safety of Tamsulosin Alone or in Combination With Solifenacin for the Treatment in Men With Lower Urinary Tract Symptoms Including Overactive Bladder Symptoms

Summary

Timeline

Drugs

Indications